Kristen Ambrose, SVP & Chief Accounting Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 2,596 shares at $480.95 ($1.3M) on 2025-02-25, disclosed to the SEC on 2025-02-26.
Scheduled sale ($1.3M) by SVP & Chief Accounting Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $483.28 | 828 | $400K | 32.0% |
| 2 | $480.95 | 884 | $425K | 34.0% |
| 3 | $480.95 | 884 | $425K | 34.0% |
| Total | $481.69 avg | 2,596 | $1.3M | 100% |
| Filing → |
| VRTX | SELL | 2026-02-19 | $1.1M | — | Filing → |
| VRTX | SELL | 2026-02-12 | $634K | — | Filing → |
| VRTX | SELL | 2025-02-19 | $611K | — | Filing → |